• Thumbnail for Tyrosinemia
    of untreated tyrosinemia include liver and kidney disturbances. Without treatment, tyrosinemia leads to liver failure. Today, tyrosinemia is increasingly...
    7 KB (685 words) - 01:50, 27 February 2022
  • Thumbnail for Tyrosinemia type I
    Tyrosinemia type I is a genetic disorder that disrupts the metabolism of the amino acid tyrosine, resulting in damage primarily to the liver along with...
    30 KB (3,369 words) - 09:15, 17 November 2023
  • Thumbnail for Tyrosinemia type II
    Tyrosinemia type II is an autosomal recessive condition with onset between ages 2 and 4 years, when painful circumscribed calluses develop on the pressure...
    4 KB (298 words) - 22:58, 6 November 2023
  • Thumbnail for Fumarylacetoacetate hydrolase
    the observed liver enzyme activity in FAH deficiency during hereditary tyrosinemia type 1. In humans, this enzyme is mainly expressed in the liver. FAH...
    21 KB (2,536 words) - 15:28, 8 July 2024
  • Thumbnail for Tyrosinemia type III
    Tyrosinemia type III is a rare disorder caused by a deficiency of the enzyme 4-hydroxyphenylpyruvate dioxygenase (EC 1.13.11.27), encoded by the gene...
    3 KB (160 words) - 22:59, 6 November 2023
  • disease G6PD deficiency Disorders of amino acid metabolism phenylketonuria tyrosinemia maple syrup urine disease glutaric acidemia type 1 Urea Cycle Disorder...
    15 KB (1,517 words) - 07:36, 14 July 2024
  • Thumbnail for Nitisinone
    effects of hereditary tyrosinemia type 1 (HT-1). It is available as a generic medication. Nitisinone is used to treat hereditary tyrosinemia type 1 (HT-1) in...
    10 KB (893 words) - 02:51, 22 June 2024
  • Thumbnail for Tyrosine aminotransferase
    deficiency of the enzyme in humans can result in what is known as type II tyrosinemia, wherein there is an abundance of tyrosine as a result of tyrosine failing...
    8 KB (965 words) - 03:44, 22 December 2023
  • Thumbnail for Keratoderma
    syndrome Corneodermatosseous syndrome Huriez syndrome Oculocutaneous tyrosinemia Cardiofaciocutaneous syndrome Schöpf–Schulz–Passarge syndrome Acquired...
    4 KB (241 words) - 21:28, 6 June 2024
  • Thumbnail for Aminolevulinic acid dehydratase deficiency porphyria
    Both lead poisoning and succinylacetone, whose levels are increased in tyrosinemia type I, inhibit ALAD. Therefore, these conditions should also be considered...
    11 KB (1,149 words) - 23:17, 20 August 2023